Through selective activation of the Wnt pathway with targeted antibodies, Surrozen is pioneering a new class of therapeutics to treat serious diseases characterized by tissue injury. Surrozen is pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues and restore organs damaged by serious disease. By designing tissue-specific antibodies that engage the body’s own biological repair mechanisms, we are developing a broad pipeline of first in class drug candidates to help patients across multiple disease areas of high unmet need. With pharmaceutical properties, this platform promises to overcome many of the current limitations of regenerative medicines.
Market Cap | 120.144 Million | Shares Outstanding | 35.027 Million | Avg 30-day Volume | 8.728 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.51 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -48.837 Million |
Price to Book Value | 1.0299 | Operating Margin | 0.0 | Enterprise Value | 1.435 Million |
Current Ratio | 11.79 | EPS Growth | 0 | Quick Ratio | 11.4 |
1 Yr BETA | 1.0659 | 52-week High/Low | 14.0 / 1.98 | Profit Margin | 0.0 |
Operating Cash Flow Growth | 0.0 | Altman Z-Score | 1.8977 | Free Cash Flow to Firm | 0 |
Earnings Report | 2022-08-10 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
WILLIAMS CHARLES O CHIEF FINANCIAL OFFICER |
|
125,000 | 2022-03-01 | 1 |
PARKER CRAIG C CHIEF EXECUTIVE OFFICER |
|
370,000 | 2022-03-01 | 1 |
VANHOVE GEERTRUI CHIEF MEDICAL OFFICER |
|
125,000 | 2022-03-01 | 1 |
YEH WEN-CHEN CHIEF SCIENTIFIC OFFICER |
|
125,000 | 2022-03-01 | 1 |
|
578,667 | 2020-12-01 | 0 | |
|
578,667 | 2020-12-01 | 0 | |
LIVINGSTON KEVIN HAROLD CHIEF FINANCIAL OFFICER |
|
578,667 | 2020-12-01 | 0 |
|
578,667 | 2020-12-01 | 0 | |
|
0 | 2020-11-18 | 0 | |
|
0 | 2020-11-18 | 0 | |
|
0 | 2020-11-18 | 0 | |
|
0 | 2020-11-18 | 0 | |
|
0 | 2020-11-18 | 0 | |
HOUSE JOSHUA CORY VP BUSINESS DEVELOPMENT |
|
0 | 2020-11-18 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
SURROZEN INC SRZN | 2022-06-24 22:15:03 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 21:45:03 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 21:15:04 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 20:45:03 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 20:15:03 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 19:45:03 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 19:15:03 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 18:45:03 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 18:15:04 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 17:45:03 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 17:15:03 UTC | -8.7391 | 10.3091 | 800000 |
SURROZEN INC SRZN | 2022-06-24 16:45:03 UTC | -8.6763 | 10.2463 | 800000 |
SURROZEN INC SRZN | 2022-06-24 16:15:03 UTC | -8.6763 | 10.2463 | 800000 |
SURROZEN INC SRZN | 2022-06-24 15:45:03 UTC | -8.6763 | 10.2463 | 800000 |
SURROZEN INC SRZN | 2022-06-24 15:15:03 UTC | -8.6763 | 10.2463 | 500000 |
SURROZEN INC SRZN | 2022-06-24 14:45:03 UTC | -8.6788 | 10.2488 | 500000 |
SURROZEN INC SRZN | 2022-06-24 14:15:03 UTC | -8.6788 | 10.2488 | 500000 |
SURROZEN INC SRZN | 2022-06-24 13:45:03 UTC | -8.6788 | 10.2488 | 500000 |
SURROZEN INC SRZN | 2022-06-24 13:15:03 UTC | -8.6788 | 10.2488 | 500000 |
SURROZEN INC SRZN | 2022-06-24 12:45:03 UTC | -8.6788 | 10.2488 | 500000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|